Medinotec Inc. financial data

Symbol
MDNC on OTC
Location
Johannesburg
Fiscal year end
28 February
Latest financial report
10-Q - Q4 2025 - 09 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 398% % 1.9%
Debt-to-equity 45% % -56%
Return On Equity 49% % 54%
Return On Assets 34% % 116%
Operating Margin 29% % 55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,755,548 shares 0.19%
Common Stock, Shares, Outstanding 11,755,548 shares 0.19%
Entity Public Float $9,157,135 USD 150%
Common Stock, Value, Issued $11,756 USD 0.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $11,399,986 USD 45%
Cost of Revenue $4,879,723 USD -166%
Research and Development Expense $121,767 USD -666%
Selling and Marketing Expense $834,323 USD 649%
General and Administrative Expense $1,255,647 USD 28%
Operating Income (Loss) $3,317,867 USD 124%
Nonoperating Income (Expense) $52,067 USD 73%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,265,800 USD 154%
Income Tax Expense (Benefit) $791,215 USD -538%
Net Income (Loss) Attributable to Parent $2,340,970 USD 200%
Earnings Per Share, Basic 0.19 USD/shares 171%
Earnings Per Share, Diluted 0.03 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $2,259,523 USD 128%
Other Assets, Current $143,725 USD 44%
Assets, Current $6,472,994 USD 32%
Property, Plant and Equipment, Net $325,916 USD -14%
Operating Lease, Right-of-Use Asset $19,173 USD -58%
Assets $6,852,928 USD 28%
Employee-related Liabilities, Current $45,324 USD 107%
Liabilities, Current $1,352,239 USD -8.3%
Deferred Income Tax Liabilities, Net $80,124 USD
Operating Lease, Liability, Noncurrent $5,355 USD -84%
Liabilities $1,352,691 USD -47%
Accumulated Other Comprehensive Income (Loss), Net of Tax $301,246 USD 292%
Stockholders' Equity Attributable to Parent $5,500,237 USD 95%
Liabilities and Equity $6,852,928 USD 28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $759,238 USD -408%
Net Cash Provided by (Used in) Financing Activities $37,900 USD 93%
Net Cash Provided by (Used in) Investing Activities $6,055 USD
Common Stock, Shares Authorized 200,000,000 shares 6.2%
Common Stock, Shares, Issued 11,755,548 shares 0.19%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $818,809 USD -183%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,856,926 USD 6.7%
Deferred Tax Assets, Valuation Allowance $462,576 USD -161%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $545,829 USD 131%
Payments to Acquire Property, Plant, and Equipment $6,055 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,565,415 USD 242%
Property, Plant and Equipment, Gross $1,642,762 USD 0%
Operating Lease, Liability, Current $21,868 USD -23%
Deferred Income Tax Expense (Benefit) $5,824 USD -4.6%
Deferred Tax Assets, Operating Loss Carryforwards $38,234 USD 121%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) $1,159,566 USD 25%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $3,405,359 USD 3.3%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years $14,277 USD -54%
Depreciation, Depletion and Amortization $7,506 USD -68%
Operating Leases, Future Minimum Payments Due, Next Twelve Months $30,556 USD
Deferred Tax Assets, Net of Valuation Allowance $83,253 USD 40%
Operating Leases, Future Minimum Payments, Due in Three Years $13,005 USD
Operating Leases, Future Minimum Payments Due $21,868 USD -55%
Interest Expense $245,608 USD -430%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares